Programmed Multiresponsive Vesicles for Enhanced Tumor Penetration and Combination Therapy of Triple‐Negative Breast Cancer
Source abstract
Abstract
Nanomedicine is a promising approach for combination chemotherapy of triple‐negative breast cancer (TNBC). However, the therapeutic efficacy of nanoparticulate drugs is suppressed by a series of biological barriers. The authors herein present a programmed stimuli‐responsive liposomal vesicle to overcome the sequential barriers for enhanced TNBC therapy. The intelligent vesicles are engineered by integrating an enzyme‐cleavable polyethylene glycol (PEG) corona, a light‐responsive photosensitizer pheophorbide a (PPa), and a temperature‐sensitive liposome (TSL) into a single nanoplatform. The resultant enzyme, light, and temperature multisensitive liposome (ELTSL) is sequentially coloaded with a lipophilic oxaliplatin prodrug of hexadecyl‐oxaliplatin carboxylic acid (HOC) and hydrophilic doxorubicin hydrochloride (DOX). Dual drug‐loaded ELTSL displays enhanced tumor penetration and increased cellular uptake upon matrix metalloproteinase 2 mediated cleavage of the PEG corona. Under NIR laser irradiation, PPa induces mild hyperthermia effect to trigger ultrafast drug release in the tumor cells. In combination with PPa‐mediated photodynamic therapy, HOC and DOX coloaded ELTSL show significantly improved antitumor efficacy than monotherapy. Given the clinically translatable potential of the liposomal vesicles, ELTSL might represent a promising nanoplatform for combination TNBC therapy.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Drug Research & Center of Pharmaceutics Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai 201203 China
School of Pharmacy Shenyang Pharmaceutical University Shenyang 110016 China
School for Radiological and Interdisciplinary Sciences (RAD‐X) Soochow University Suzhou 215123 China
Funding
National Natural Science Foundation of China · Chinese Academy of Sciences · Youth Innovation Promotion Association of the Chinese Academy of Sciences
References (59)
Show source-provided references
1. 10.1016/j.cell.2015.08.06310.1016/j.cell.2015.08.063 ↗
2. Crunkhorn S. · Nat. Rev. Drug Discovery · 2016 · 15 · 532
3. Keane T. E. · Cancer Res. · 1994 · 54 · 475
4. 10.1038/nbt0206-16310.1038/nbt0206-163 ↗
5. 10.1021/nn401079610.1021/nn4010796 ↗
6. 10.1038/nbt.154910.1038/nbt.1549 ↗
7. 10.1016/j.addr.2009.05.00610.1016/j.addr.2009.05.006 ↗
8. 10.1021/mp200243k10.1021/mp200243k ↗
9. 10.1016/j.addr.2015.10.01910.1016/j.addr.2015.10.019 ↗
10. 10.1021/mp400610b10.1021/mp400610b ↗
11. Straubinger R. M. · Cancer Res. · 1988 · 48 · 5237
12. 10.1016/j.biomaterials.2015.09.02210.1016/j.biomaterials.2015.09.022 ↗
13. 10.1073/pnas.101136810710.1073/pnas.1011368107 ↗
14. 10.1073/pnas.85.18.694910.1073/pnas.85.18.6949 ↗
15. 10.1200/JCO.2001.19.5.144410.1200/JCO.2001.19.5.1444 ↗
16. 10.1038/ncomms528010.1038/ncomms5280 ↗
17. 10.1021/nn201390410.1021/nn2013904 ↗
18. 10.1016/j.jconrel.2012.03.02010.1016/j.jconrel.2012.03.020 ↗
19. 10.1517/1354378090311416810.1517/13543780903114168 ↗
20. 10.1021/nn302148p10.1021/nn302148p ↗
21. 10.1038/nbt.333010.1038/nbt.3330 ↗
22. 10.1073/pnas.152208011310.1073/pnas.1522080113 ↗
23. 10.1002/anie.20120772110.1002/anie.201207721 ↗
24. 10.1021/nl103373310.1021/nl1033733 ↗
25. 10.1021/nn205023w10.1021/nn205023w ↗
26. 10.1158/1078-0432.CCR-03-003510.1158/1078-0432.CCR-03-0035 ↗
27. Kneidl B. · Int. J. Nanomed. · 2014 · 9 · 4387
28. Needham D. · Cancer Res. · 2000 · 60 · 1197
29. 10.1016/j.biomaterials.2012.03.01810.1016/j.biomaterials.2012.03.018 ↗
30. 10.1021/acs.chemrev.5b0057810.1021/acs.chemrev.5b00578 ↗
31. 10.1016/j.jconrel.2010.01.00610.1016/j.jconrel.2010.01.006 ↗
32. 10.1016/j.jconrel.2013.03.01110.1016/j.jconrel.2013.03.011 ↗
33. 10.1007/s11095-010-0154-210.1007/s11095-010-0154-2 ↗
34. 10.1016/j.jconrel.2010.03.01610.1016/j.jconrel.2010.03.016 ↗
35. 10.1021/nn101937h10.1021/nn101937h ↗
36. 10.1021/nn300524f10.1021/nn300524f ↗
37. 10.1021/cr900236h10.1021/cr900236h ↗
38. 10.1021/acs.nanolett.6b0199410.1021/acs.nanolett.6b01994 ↗
39. 10.1007/s10549-009-0654-010.1007/s10549-009-0654-0 ↗
40. 10.1016/j.ccr.2005.05.02410.1016/j.ccr.2005.05.024 ↗
41. 10.1016/S0927-7765(99)00156-310.1016/S0927-7765(99)00156-3 ↗
42. 10.1038/nrd103310.1038/nrd1033 ↗
43. 10.1002/adfm.20120221510.1002/adfm.201202215 ↗
44. 10.1016/j.ygyno.2005.08.02010.1016/j.ygyno.2005.08.020 ↗
45. 10.1200/JCO.1989.7.5.57210.1200/JCO.1989.7.5.572 ↗
46. 10.1200/JCO.2003.02.50510.1200/JCO.2003.02.505 ↗
47. 10.1002/adfm.20160296310.1002/adfm.201602963 ↗
48. 10.7150/thno.1351510.7150/thno.13515 ↗
49. 10.1073/pnas.130395811010.1073/pnas.1303958110 ↗
50. 10.1016/j.biomaterials.2012.05.04910.1016/j.biomaterials.2012.05.049 ↗
51. 10.1038/nrm185810.1038/nrm1858 ↗
52. 10.1002/ijc.2943010.1002/ijc.29430 ↗
53. 10.1093/jnci/djk00510.1093/jnci/djk005 ↗
54. 10.1038/ncomms571210.1038/ncomms5712 ↗
55. 10.1021/nl504537810.1021/nl5045378 ↗
56. 10.1158/1078-0432.CCR-06-244310.1158/1078-0432.CCR-06-2443 ↗
57. 10.1038/ncomms900310.1038/ncomms9003 ↗
58. 10.1002/adfm.20160170310.1002/adfm.201601703 ↗
59. 10.1016/j.biomaterials.2015.06.01710.1016/j.biomaterials.2015.06.017 ↗